Albupad
Albumin-based biomaterials for drug delivery and tissue engineering in human and veterinary therapeutics
Highlights
- Young companyFounded 2024
- New on EvolcAdded 2026-11-09
About Albupad
Albupad develops albumin-based biomaterials made entirely from albumin, with applications in drug delivery and tissue engineering. The materials are designed for tunable formulations and use in human or veterinary therapies.
The company is a spin-off from a biomedical research center and receives R&D support from it. Its team works in formulation, characterization, encapsulation, vectorization and preclinical development, and collaborates with CROs and CDMOs.
Founded in 2024, Albupad is based in Strasbourg, France. It announced a €1.3 million funding round in March 2026.
Product: Albumin-based biomaterials for drug delivery and tissue engineering.
Jobs at Albupad
Leadership
- Jordan Beurton · CSOSource: company website
- Eya ALOUI · Présidente & CEOSource: company website
More biotech & pharma companies
Algaia
Seaweed-based ingredients, cosmetic actives and R&D services for food, agriculture, cosmetics and health clientsNew on EvolcAlliance Bio Expertise
Automated microbiology lab equipment and culture media for food, cosmetics, pharma and clinical labsNew on EvolcAllogenica
Develops stem-cell-derived allogeneic T-cell therapies for cancer, rare diseases and autoimmune disordersYoung companyNew on EvolcAlsinova
Contract research services for pharma, medtech, cosmetics and veterinary sponsors, from preclinical studies to early access programsNew on EvolcAmbiotis
Contract research on inflammation resolution and lipid analytics for pharma, dermo-cosmetic and nutraceutical companiesNew on EvolcAmgen
Biotechnology company developing and manufacturing therapies for serious diseases, operating in FranceNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
